• Henriette Poaty, Guy Emergence Poaty, Gilbert NDziessi, Emile Godefroy Ngakeni, Tatiana Doukaga Makouka, René Soussa Gadoua, Regis Ondzé, Lambert Kitembo, Presley Jeanel Msengui, Jethro Massala Peya, Michel Gbala Sapoulou, Pascal Ibata, Henri Germain Monabeka, and Alexis Elira Dokekias.
• Faculty of Health Sciences, University Marien Ngouabi, Brazzaville, Congo.
• Afr Health Sci. 2021 Sep 1; 21 (3): 1100-1106.

BackgroundThe global pandemic Coronavirus Disease 2019 (COVID-19) due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is reported to be potentially severe in patients with morbid conditions. One common reported comorbidities is diabetes. We aimed in this study to precise the clinical characteristics and outcomes in a series of congolese diabetic patients affected by COVID-19 infection.Patients And MethodsWe retrospectely studied from 256 COVID-19 patients, a cohort of 30 persons with previously known diabetes. The glycaemia controls have been obtained by plasma glucose assay. All patients have been tested positive to SARS-CoV-2 by RT-PCR method.ResultsThe COVID-19 diabetic patients represented 11,7% of all COVID-19 patients with confidence interval of 95% [7,77-15,65]. Older individuals and male sex were predominent. Dyspnea and sauration of oxygen < 90 were significatives and added risk factors were noted in 63.3% of patients, particulary hyperglycaemia with hypertension or obesity. The mortality rate at the percentage of 36.7% was more prevalent in patients with added comorbidities (30%) versus without comorbidities (6.7%).ConclusionCongolese COVID-19 diabetic patients of male sex and older age exhibiting arterial hypertension and obesity are the most exposed to severe COVID-19 and increasead mortality rate.© 2021 Poaty H et al.

11 keywords...

hide…